Efficacy and safety of Traditional Chinese Medicine injections for no-reflow or slow flow in patients with acute coronary syndrome after percutaneous coronary intervention: a systematic review and network meta-analysis.

ABSTRACT:

Introduction

: There is a possibility of ischemia-reperfusion injury following percutaneous coronary intervention (PCI). Traditional Chinese medicine (TCM) treatment features multi-target and multi-link interventions, along with relatively good safety profiles, making it a promising option for alleviating ischemia-reperfusion injury following PCI.

Methods

We searched the China National Knowledge Infrastructure (CNKI), VIP Journal Database, China Biomedical Literature Database, Wanfang Medical Database, PubMed, Web of Science, Embase, and Cochrane Library for randomized controlled trials published in Chinese and English regarding Chinese herbal injections for treating no-reflow or slow-reflow after PCI, from database inception to November 30, 2024.

Results

A total of 1

SUBMITTER: Cai T 

PROVIDER: S-EPMC12819830 | biostudies-literature | 2025

REPOSITORIES: biostudies-literature